In vitro toxicology consists of using cells or tissues maintained or grown in controlled laboratory conditions to examine the toxic properties of compounds and mixtures. Gen Consulting Company predicts that the global in-vitro toxicology testing market is estimated to touch a valuation of USD 11,592 million, registering a CAGR of 7.2% during the forecast period (2021-2027).

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global in-vitro toxicology testing market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the in-vitro toxicology testing industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the components, toxicological endpoint, end use, and region. The global market for in-vitro toxicology testing can be segmented by components: instrument, reagents & kits, software, services. According to the research, the reagents & kits segment had the largest share in the global in-vitro toxicology testing market. In-vitro toxicology testing market is further segmented by toxicological endpoint: ADME (absorption, distribution, metabolism, excretion), cytotoxicity test, genotoxicity testing, ocular toxicity, organ toxicity, phototoxicity testing, skin toxicity, others. Based on end use, the in-vitro toxicology testing market is segmented into: pharmaceutical & biotechnology, CROs, personal care products, research institutes, chemical, others. On the basis of region, the in-vitro toxicology testing market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW).

By components:
– instrument
– reagents & kits
– software
– services

By toxicological endpoint:
– ADME (absorption, distribution, metabolism, excretion)
– cytotoxicity test
– genotoxicity testing
– ocular toxicity
– organ toxicity
– phototoxicity testing
– skin toxicity
– others

By end use:
– pharmaceutical & biotechnology
– CROs
– personal care products
– research institutes
– chemical
– others

By region:
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)

The report explores the recent developments and profiles of key vendors in the Global In-vitro Toxicology Testing Market, including Abbott Laboratories, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Catalent, Inc., Charles River Laboratories International, Inc., GE Healthcare, Lonza Group AG, PerkinElmer, Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report
– To analyze and forecast the market size of the global in-vitro toxicology testing market.
– To classify and forecast the global in-vitro toxicology testing market based on components, toxicological endpoint, end use, region.
– To identify drivers and challenges for the global in-vitro toxicology testing market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global in-vitro toxicology testing market.
– To identify and analyze the profile of leading players operating in the global in-vitro toxicology testing market.

Why Choose This Report
– Gain a reliable outlook of the global in-vitro toxicology testing market forecasts from 2021 to 2027 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.